Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Of Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03190174
What this trial is testing

Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

Who this might be right for
Ewing SarcomaPEComaEpithelioid Sarcoma+11 more
Sarcoma Oncology Research Center, LLC 34
Testing effectiveness (Phase 2)Study completedNCT03587662
What this trial is testing

Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Metastatic Kidney Medullary CarcinomaMetastatic Renal Cell CarcinomaSMARCB1 Negative+2 more
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT02855203
What this trial is testing

Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours

Who this might be right for
Renal Cell Carcinoma
Peter MacCallum Cancer Centre, Australia 30
Testing effectiveness (Phase 2)UnknownNCT00025103
What this trial is testing

Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney

Who this might be right for
Kidney Cancer
Children's Cancer and Leukaemia Group 75
Not applicableStudy completedNCT05112627
What this trial is testing

Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy

Who this might be right for
Metastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
Mayo Clinic 15
Testing effectiveness (Phase 2)UnknownNCT05096390
What this trial is testing

Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC

Who this might be right for
Papillary Renal Cell Carcinoma Type 2
Centre Leon Berard 72
Early research (Phase 1)Ended earlyNCT06285097
What this trial is testing

PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors

Who this might be right for
NeoplasmsNon-small-cell Lung CancerMelanoma+5 more
Pfizer 9
Very early researchEnded earlyNCT01086696
What this trial is testing

A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers

Who this might be right for
Breast CancerLung CancerRenal Cancer+1 more
National Cancer Institute (NCI) 6
Early research (Phase 1)Ended earlyNCT00158886
What this trial is testing

Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 26
Very early researchUnknownNCT05638256
What this trial is testing

68Ga-labeled NY104 PET Imaging in Patients

Who this might be right for
Renal Cell Carcinoma
Affiliated Hospital of Jiangnan University 10
Early research (Phase 1)Looking for participantsNCT07148050
What this trial is testing

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

Who this might be right for
Solid Tumor (Excluding CNS)Liver Cell CarcinomaMalignant Rhabdoid Tumor+7 more
Seattle Children's Hospital 21
Testing effectiveness (Phase 2)Study completedNCT01399918
What this trial is testing

Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center 57
Not applicableUnknownNCT02073110
What this trial is testing

Optical Biopsy to Improve the Diagnosis of Kidney Cancer

Who this might be right for
Kidney Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 194
Testing effectiveness (Phase 2)Active Not RecruitingNCT04413123
What this trial is testing

Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC

Who this might be right for
Papillary Renal Cell CarcinomaUnclassified Renal Cell CarcinomaTranslocation Renal Cell Carcinoma+5 more
Bradley A. McGregor, MD 60
Not applicableEnded earlyNCT05534789
What this trial is testing

Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study).

Who this might be right for
Carcinoma, Renal Cell
Pfizer 106
Not applicableStudy completedNCT04375150
What this trial is testing

Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC

Who this might be right for
Renal Cell Carcinoma (RCC)
Pfizer 355
Testing effectiveness (Phase 2)Study completedNCT00069160
What this trial is testing

Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer

Who this might be right for
Lung NeoplasmsOvarian NeoplasmsCervix Neoplasms+1 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT03438708
What this trial is testing

Prior Axitinib as a Determinant of Outcome of Renal Surgery

Who this might be right for
Clear Cell Renal Cell Carcinoma
University of California, San Diego 22
Testing effectiveness (Phase 2)Study completedNCT02019576
What this trial is testing

Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With Sunitinib

Who this might be right for
Clear Cell Metastatic Renal Cell Carcinoma
Sunnybrook Health Sciences Centre 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07593040
What this trial is testing

Pembrolizumab Plus Belzutifan With or Without Lenvatinib in Localized Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Vall d'Hebron Institute of Oncology 150
Next Page